Castration Resistant Prostate Cancer — OGX-427 in Castration Resistant Prostate Cancer Patients
Citation(s)
A Randomized Phase II Study of OGX-427 (a Second-Generation Antisense Oligonucleotide to Heat Shock Protein-27) in Patients With Castration Resistant Prostate Cancer Who Have Not Previously Received Chemotherapy for Metastatic Disease